B Activ 90 Capsules by Xymogen

B Activ 180 C

Xymogen

$78.99
(No reviews yet) Write a Review
SKU:
XY-B-ACTIV-180-1
Availability:
Usually Ships in 48 to 72 Hours
Already Registered?
How to Gain Access to Store?

B Activ 180 Capsules by Xymogen

B Active 180c is a supplement by Xymogen, a brand known for professional formulas based on thorough research.* This stress-alleviating supplement may support your nervous system, promote your cardiovascular health and even help you with carbohydrate metabolism.* This makes B Activ 180c a versatile dietary supplement.*

Who Should Consider B Activ 180c by Xymogen?

B Activ 180 capsules may support your health if you:

  • don’t consume sufficient amounts of vitamin B in your diet*
  • suffer from symptoms such as:
    • fatigue*
    • mental fog*
  • experience a lot of stress on a daily basis*

B Activ 180c—Effects?

B Activ 180c by Xymogen may:

  • promote a healthy carbohydrate metabolism*
  • support your nervous system*
  • help maintain your cardiovascular health*
  • enhance your mood and mental function*

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about B Activ 180 capsules.

Recommendation:
Xymogen suggests taking one capsule once or twice daily, or as directed by your healthcare professional.

Serving Size: 1 Capsule
Servings Per Container: 180

Amount Per Serving:
Thiamin (as thiamine HCl) 20 mg
Riboflavin (as riboflavin 5’-phosphate sodium) 20 mg
Niacin (130 mg as niacinamide and 10 mg as niacin) 140 mg
Vitamin B6 (as pyridoxal-5’-phosphate) 20 mg
Folate (as Quatrefolic® (6S)-5-methyltetrahydrofolic acid, glucosamine salt) 400 mcg DFE
Vitamin B12 (as MecobalActive™ methylcobalamin) 400 mcg
Biotin 400 mcg
Pantothenic Acid (as d-calcium pantothenate) 150 mg
Choline (as choline dihydrogen citrate) 30 mg
Benfotiamine 20 mg

Other Ingredients: Capsule (hypromellose and water), stearic acid, magnesium stearate, and silica.

Does Not Contain: Gluten, wheat, yeast, corn protein, soy, dairy or animal products, artificial sweeteners or colors, or preservatives.

Storage: Store tightly closed in a dry, cool place.

Trademarks:
S1. Quatrefolic® is a registered trademark of Gnosis S.p.A. Produced under U.S. Patent 7,947,662.

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Click here to view Data Sheet

LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited. covenanthealthproducts.com makes XYMOGEN formulas available only to patients of our clinic. If you are a patient of covenanthealthproducts.com, you may inquire about XYMOGEN by calling (800) 627-6518

References:

  1. Ayazpoor, U. (2001). Chronic alcohol abuse. Benfotiamine in alcohol damage is a must [in German]. MMW Fortschritte der Medizin, 143(16), 53. [PMID: 11367995]
  2. Halsted, C. H., Villanueva, J. A., & Devlin, A. M. (2002). Folate deficiency, methionine metabolism, and alcoholic liver disease. Alcohol, 27(3), 169–172. [PMID: 12163145]
  3. Kluijtmans, L. A., Van den Heuvel, L. P., Boers, G. H., et al. (1996). Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. American Journal of Human Genetics, 58(1), 35–41. [PMID: 8554066]
  4. Labadarios, D., Rossouw, J. E., McConnell, J. B., et al. (1977). Vitamin B6 deficiency in chronic liver disease – evidence for increased degradation of pyridoxal-5-phosphate. Gut, 18, 23–27. [PMID: 838399]
  5. Loew, D. (1996). Pharmacokinetics of thiamine derivatives especially of benfotiamine. International Journal of Clinical Pharmacology and Therapeutics, 34(2), 47–50. [PMID: 8929745]
  6. Schupp, N., Schmid, U., Heidland, A., et al. (2008). New approaches for the treatment of genomic damage in end-stage renal disease. Journal of Renal Nutrition, 18(1), 127–133. [PMID: 18089459]
  7. Stirban, A., Negrean, M., Stratmann, B., et al. (2006). Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care, 29(9), 2064–2071. [PMID: 16936154]
  8. Thornalley, P. J. (2005). The potential role of thiamine (vitamin B1) in diabetic complications. Current Diabetes Reviews, 1(3), 287–298. [PMID: 18220605]
  9. Willems, F. F., Boers, G. H., Blom, H. J., et al. (2004). Pharmacokinetic study on the utilization of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease. British Journal of Pharmacology, 41(5), 825–830. [PMID: 14769778]
  10. Woelk, H., Lehrl, S., Bitsch, R., et al. (1998). Benfotiamine in treatment of alcoholic polyneuropathy: An 8-week randomized controlled study (BAP I Study). Alcohol, 33(6), 631–638. [PMID: 9872352]
  11. Yakut, M., Ustün, Y., Kabaçam, G., et al. (2010). Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. European Journal of Internal Medicine, 21(4), 320–323. [PMID: 20603044]